France Contraceptive Devices Market cover

France Contraceptive Devices Market

  • HC-3430
  • 4.5 Rating
  • 190 Pages
  • Upcoming
  • 63 Reviews
  • PDF Excel PPT
raksha

Author:

Raksha Sharma

Vineet

Fact-checked by:

Vineet Pandey

Shreyas

Editor:

Shreyas Tandon

France Contraceptive Devices Market Outlook 2031:

The France contraceptive devices market size was valued at USD 355 Million in 2022 and is projected to reach USD 652.65 Million by 2031, expanding at a CAGR of 7% during the forecast period 2023 - 2031. The growth of the market is attributed to the French people becoming more aware about contraception options.

The regional market is developing as the prevalence of sexually transmitted diseases rises and the necessity for population control grows. For example, according to the Institute for Health Metrics and Evaluation, 9.27 million people in France were living with HIV/AIDS and sexually transmitted diseases in 2019.

Contraceptive Devices Market Outlook

Despite the high prevalence of contraception in France, a large percentage of pregnancies are unplanned. Following the 2012 pill scare, the contraceptive technique mix has become more diverse, with tablets and intrauterine devices (IUD) dominating.

In 2020, the government reported that about 1,000 girls aged 12 to 14 got pregnant in France, with 770 of those pregnancies ending in abortion. According to government estimates, since free contraception was made available to 15- to 18-year-olds, the number of abortions has decreased from 9.5 per 1,000 pregnancies in 2012 to six in 2018.

Due to the risks associated with the pill, as well as the development of alternative and less restrictive methods of birth control, women in France are increasingly relying on methods other than the pill. The IUD is now the most popular procedure. However, it is still frequently recommended, primarily to women over the age of thirty or who have previously had children. Young women at the start of their sexual lives.

On the other hand, girls and men aged twelve to twenty-five are more likely to use condoms, which also provide protection against sexually transmitted diseases.

The French government is also taking various measures to control birth control, particularly among young girls. The French government announced on September 9, 2021 that it would make birth control free for all women under the age of twenty-five, broadening an initiative that young women under the age of eighteen.

In France, there are a variety of contraceptive techniques to choose from such as cervical caps, sponges, intrauterine device (IUD), injection, and implantation of hormonal contraceptive methods now available on the market.

The hormone exposure is either constant or intermittent, depending on the type of hormonal contraception used. All hormonal contraceptive methods work by preventing a fertilized egg from being implanted in the female's womb (uterus) and starting to develop, or by stopping sperm and egg from fertilizing.

Contraceptive Devices Market Trends, Drivers, Restraints, and Opportunities

  • Urbanization, and increasing population are expected to boost the market during the forecast period.
  • Rising awareness for sexually transmitted diseases is expected to fuel the market growth during the forecast period.
  • Growing inflation and increasing trend for nuclear families is expected to drive the market expansion in coming years.
  • Rising instances of unplanned pregnancy are anticipated to surge the market.
  • Awareness for modern contraception is key factors pushing the market in the coming years.
  • Government efforts for improving and controlling birth are major factors boosting the market growth in the coming years
  • Lack of awareness for usage of contraceptives are expected to hinder the market.
  • High cost of contraceptive devices seems to unaffordable to many individuals is projected to restrict the market.
  • Research and development in of products are projected to create lucrative opportunities for the market players.

Scope of the Contraceptive Devices Market Report

The report on the France contraceptive devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

France Contraceptive Devices Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Types (Diaphragms, Cervical Caps, Sponges, Condoms, Intra Uterine Device (IUD), Vaginal Rings, and Others) and Gender (Male, and female)

Country Scope

France

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

AbbVie Inc. (Allergan); Pfize; Bayer AG; Reckitt Benckiser; Cooper Surgical Inc

France Contraceptive Devices Market Segment Insights

The condoms segment is projected to constitute a key market share

Based on types, the France contraceptive devices market is divided into diaphragms, cervical caps, sponges, condoms, intra uterine device (IUD). The condoms segment is expected to account for a key share of the market during the forecast period owing to high adoption of condoms due its low cost and also helps in reducing the risk for STDs.

Contraceptive Devices Market Types

The female segment is expected to expand at a rapid pace

In terms of gender, the France contraceptive devices market is segmented into male, and female. The female segment is expected to hold a key share of the market in the coming years due to rising awareness among females for use of contraceptives to prevent unintended pregnancy.

Contraceptive Devices Market

Segments

The France contraceptive devices market has been segmented on the basis of

Types

  • Diaphragms
  • Cervical Caps
  • Sponges
  • Condoms
  • Intra Uterine Device (IUD)
  • Vaginal Rings
  • Others

Gender

  • Male
  • Female

Country

  • France

Key Player

Competitive Landscape

Key players competing in the France contraceptive devices market include AbbVie Inc. (Allergan); Pfize; Bayer AG; Reckitt Benckiser; Cooper Surgical Inc.

Some of these players are coming up with several market strategies including mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.
Contraceptive Devices Market Key Players
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. contraceptive devices Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. contraceptive devices Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. contraceptive devices Market - Supply Chain
  4.5. Global contraceptive devices Market Forecast
     4.5.1. contraceptive devices Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. contraceptive devices Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. contraceptive devices Market Absolute $ Opportunity
5. Global contraceptive devices Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. contraceptive devices Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global contraceptive devices Demand Share Forecast, 2019-2026
6. North America contraceptive devices Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America contraceptive devices Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America contraceptive devices Demand Share Forecast, 2019-2026
7. Latin America contraceptive devices Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America contraceptive devices Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America contraceptive devices Demand Share Forecast, 2019-2026
8. Europe contraceptive devices Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe contraceptive devices Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe contraceptive devices Demand Share Forecast, 2019-2026
9. Asia Pacific contraceptive devices Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific contraceptive devices Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific contraceptive devices Demand Share Forecast, 2019-2026
10. Middle East & Africa contraceptive devices Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa contraceptive devices Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa contraceptive devices Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global contraceptive devices Market: Market Share Analysis
  11.2. contraceptive devices Distributors and Customers
  11.3. contraceptive devices Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. AbbVie Inc. (Allergan)
     11.4.2. Pfize
     11.4.3.  Bayer AG
     11.4.4.  Reckitt Benckiser
     11.4.5.  Cooper Surgical Inc

Purchase Premium Report